-0.98  /  -1.04%

93.79

NAV on 2020/10/20
NAV on 2020/10/19 94.77
52 week high on 2020/08/13 100.46
52 week low on 2020/09/18 92.54
Total Expense Ratio on 0
Total Expense Ratio (performance fee) on 0
NAV
Incl Dividends
1 month change -1.87% -1.87%
3 month change 0% 0%
6 month change 0% 0%
1 year change 0% 0%
5 year change 0% 0%
10 year change 0% 0%
Price data is updated once a day.
Click and drag to zoom in on timeline.
  • Sectoral allocations
Liquid Assets 0.03 0.01%
Offshore 216.08 99.98%
  • Top five holdings
JOHNSON&JOHN 13.32 6.17%
UNITEDHEALTH 9.96 4.61%
ROCHE 8.39 3.88%
MERCK&CO 7.16 3.31%
NOVARTIS 6.95 3.22%
  • Performance against peers
  • Fund data  
Management company:
Sygnia Collective Investments RF (Pty) Ltd
Formation date:
2020/08/06
ISIN code:
ZAE000289054
Short name:
U-HEAINSY
Risk:
Unknown
Sector:
Global--Equity--General
Benchmark:
MSCI World Health Care Net Total Return
Email
info@sygnia.co.za

Website
www.SYGNIA.co.za

Telephone
021-446-4940

  • Fund management  
Kyle Hulett
Kyle has over 16 years of multi organizational investment experience and is an accomplished money manager. He brings experience from established industry players such as Cadiz Asset Management, Prescient Securities and Symmetry where he occupied portfolio management roles in the absolute return space.
Monique Davidson


  • Fund manager's comment
No fund manager's comment available.
  • Fund focus and objective  
The Sygnia Health Innovation Global Equity Fund is a global–equity–general portfolio that seeks to deliver long-term capital growth by investing in predominantly foreign, financially sound equity securities, preference shares, property-related assets, fixed income securities and assets in liquid form, regardless of whether such securities, instruments or assets are listed or unlisted.
As a global healthcare unit trust, the fund provides South African investors with exposure to a global, uncorrelated, thematic growth sector that helps hedge medical liabilities; it also provides ESG principles. The fund offers exposure to key health companies and the accelerated earnings growth cycle they aim to achieve. The portfolio may hold a variety of securities but focuses on companies with direct or indirect exposure to the healthcare sector, which may include pharmaceutical, biotechnology, nanotechnology, information technology, nutrition, well-being and fitness, genetic engineering, medical robotics, nano-microbot and medical 3D-printing technologies. The underlying portfolio is actively managed in terms of sector and geographical allocation.
NEWSLETTERS WEB APP SHOP PORTFOLIO TOOL TRENDING CPD HUB

Follow us:

Search Articles:Advanced Search
Click a Company: